Sort
15,842 grants matching “pancreatic cancer”
ASCORBATE-INDUCED RADIOSENSITIZATION IN PANCREATIC CANCER
$164,213Joseph J Cullen · University Of Iowa · U01 · FY2012 · CA
Anti-pancreatic tumorigenesis by inactivation of SAG/RBX2 E3 ubiquitin ligase
$164,034Yi Sun · University Of Michigan At Ann Arbor · R21 · FY2014 · CA
Combination of tumor targeted therapy with stroma modulating agent for PDAC
$164,000Ketankumar D. Patel · St. John'S University · R16 · FY2024 · GM
Combination of tumor targeted therapy with stroma modulating agent for PDAC
$164,000Ketankumar D. Patel · St. John'S University · R16 · FY2025 · GM
Dissecting clonal determinants of platinum/PARP inhibitor cross-resistance in ovarian cancer
$164,000Francesca Citron · University Of Tx Md Anderson Can Ctr · R03 · FY2025 · CA
Combination of tumor targeted therapy with stroma modulating agent for PDAC
$164,000Ketankumar D. Patel · St. John'S University · R16 · FY2023 · GM
P-4: Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma
$163,953Michel M Ouellette · University Of Nebraska Medical Center · P50 · FY2008 · CA
Development of Oncolytic Adenovirus Targeting Pancreatic Cancer Stem Cells
$163,881David T Curiel · University Of Alabama At Birmingham · P50 · FY2012 · CA
Ki-Ras Signaling in Pancreatic Cancer: Role of a Novel Akt Regulator
$163,879Sushovan Guha · University Of Texas Hlth Sci Ctr Houston · R21 · FY2012 · CA
EXPERIMENTAL PATHOLOGY CORE
$163,832Gerald C Chu · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
Interrogation of the Impact of Selection on the Evolution of Human PancreaticCancer Precursor Lesions
$163,750Laura Delong Wood · Johns Hopkins University · U01 · FY2024 · CA
Dissecting the Role of Germline Genetics in RAS-Driven Cancers
$163,728Ryan Lewis Collins · Dana-Farber Cancer Inst · K99 · FY2024 · CA
Dissecting the Role of Germline Genetics in RAS-Driven Cancers
$163,728Ryan Lewis Collins · Dana-Farber Cancer Inst · K99 · FY2025 · CA
Molecular Imaging of Cachexia in Pancreatic Cancer
$163,675Zaver M Bhujwalla · Johns Hopkins University · R01 · FY2018 · CA
Phosphorylated Form of Activated IKKbeta and Pancreatic Cancer
$163,669Amarnath Natarajan · University Of Nebraska Medical Center · R21 · FY2014 · CA
Improving the radiation therapeutic ratio by inhibiting proinflammatory cytokines
$163,669Jae Ho Kim · Henry Ford Health System · R21 · FY2018 · CA
Image-Guided Nanoembolization for the Treatment of Pancreatic Cancer
$163,548Reed A. Omary · Northwestern University At Chicago · U54 · FY2014 · CA
Novel Cell Cycle Therapeutic Targets in Pancreatic Cancer
$163,507Steven F Dowdy · University Of California, San Diego · R21 · FY2014 · CA
Fusion gene mutations as biomarkers of pancreatic cancer lymph node metastases
$163,506E Aubrey Thompson · Mayo Clinic Jacksonville · R21 · FY2011 · CA
PET Imaging of the Tumor Microenvironment for Cancer Detection
$163,505Thaddeus J Wadas · University Of Iowa · R21 · FY2019 · CA
Zebrafish studies of exocrine pancreatic precursors
$163,500Johns Hopkins University · R21 · FY2005 · DK
Cancer Center Support Grant (CCSG)
$163,414George J Weiner · University Of Iowa · P30 · FY2019 · CA
Exploiting Novel Pathways to Treat Pancreatic Cancer
$163,350Keith R Johnson · University Of Nebraska Medical Center · R21 · FY2009 · CA
Proteomics Shared Resource
$163,343Akhilesh Pandey · Mayo Clinic Rochester · P30 · FY2020 · CA
Regulation of heparanase in cancer progression
$163,342Israel Vlodavsky · Technion-Israel Institute Of Technology · R01 · FY2013 · CA